Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 25, No 2 (January 10), 2007: pp. 203-208
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.07.9202

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knudsen, A. B.
Right arrow Articles by Gazelle, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knudsen, A. B.
Right arrow Articles by Gazelle, G. S.

REVIEW ARTICLE

Use of Modeling to Evaluate the Cost-Effectiveness of Cancer Screening Programs

Amy B. Knudsen, Pamela M. McMahon, G. Scott Gazelle

From the Harvard Medical School and Massachusetts General Hospital, Boston, MA

Address reprint requests to G. Scott Gazelle, MD, MPH, PhD, Institute for Technology Assessment, 101 Merrimac St 10th floor, Boston, MA 02114; e-mail: scott{at}mgh-ita.org

Cost-effectiveness analysis (CEA) is an analytic tool that provides a framework for comparing the health benefits and resource expenditures associated with competing medical and public health interventions, thereby allowing decision makers to identify interventions that yield the greatest amount of health, given their resource constraints. Models are important components of most, if not all, CEAs, and they play a key role in evaluating the cost-effectiveness of cancer screening programs, in particular. In this article, we describe the basic types of models used to evaluate cancer screening programs and provide examples of the use of models in CEAs and to guide cancer screening policy. Finally, we offer some suggestions for important concepts to consider when interpreting model results.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.




This article has been cited by other articles:


Home page
RadiologyHome page
P. M. McMahon, C. Y. Kong, B. E. Johnson, M. C. Weinstein, J. C. Weeks, K. M. Kuntz, J.-A. O. Shepard, S. J. Swensen, and G. S. Gazelle
Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study
Radiology, May 5, 2008; (2008) 2481071446.
[Abstract] [Full Text]


Home page
JCOHome page
N. J. Meropol and K. A. Schulman
Perspectives on the Cost of Cancer Care
J. Clin. Oncol., January 10, 2007; 25(2): 169 - 170.
[Full Text] [PDF]


Home page
JCOHome page
N. J. Meropol and K. A. Schulman
Cost of Cancer Care: Issues and Implications
J. Clin. Oncol., January 10, 2007; 25(2): 180 - 186.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online